Physician profile
Stanley A Lee
NPI 1700339892
$33,417.15
in general payments reported to CMS, 2019-2025
14 companies · $31K in 2025
The $31K reported for 2025 was more than what 99% of Pediatric Pulmonology providers received nationally (typical 2025 total: $140).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $324 · 2023: $1,082 · 2024: $868 · 2025: $31K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $27K · Food and Beverage: $3,629 · Travel and Lodging: $2,620 · Education: $163.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $26,680.50 |
| Food and Beverage | $3,629.46 |
| Travel and Lodging | $2,620.36 |
| Education | $162.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $30,602.10 | 2023-2025 | Dupixent |
| Astrazeneca Pharmaceuticals Lp | $836.90 | 2022-2025 | Tezspire, Fasenra |
| Genzyme Corporation | $416.65 | 2023-2025 | |
| Electromed, INC. | $384.25 | 2023-2025 | Smartvest |
| Glaxosmithkline, LLC. | $287.59 | 2023-2025 | Nucala |
| Baxter Healthcare | $196.17 | 2022-2025 | Hillrom - Volara System, Hillrom - Synclara Cough System, Hillrom - Vest System Model 105 Home Care |
| Philips North America LLC | $188.10 | 2023-2025 | Vest Therapy Und, (Ak6) Vest Therapy |
| Pulmonx Corporation | $144.66 | 2023 | Zephyr Endobronchial Valve, Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter |
| Vertex Pharmaceuticals Incorporated | $121.99 | 2025 | |
| Biogen, INC. | $99.99 | 2022 | |
| Sanofi-Aventis U.S. LLC | $67.99 | 2025 | |
| Mylan Specialty L.P. | $28.14 | 2022 | |
| Abbvie INC. | $26.27 | 2023 | |
| Alcresta Therapeutics, INC. | $16.35 | 2025 | Relizorb |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stanley Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.